From Name

From Email

To Name

To Email

Message

FDA greenlights PET imaging agent for breast cancer

from Health Imaging

FDA greenlights PET imaging agent for breast cancer Health Imaging The Food and Drug Administration has approved its first F-18 PET imaging agent specifically for use in patients with recurrent or metastatic breast cancer, according to a May 27 announcement. The companies said their radiopharmaceutical will be commercially available later this year or early next year through PETNET Solutions. READ MORE

more